Omacor and Cardioversion - a phase IV clinical study of FDA data

Summary:

Cardioversion is reported as a side effect among people who take Omacor (omega-3acid ethyl esters), especially for people who are male, 60+ old, also take Tasigna, and have Acute coronary syndrome.

The phase IV clinical study analyzes which people have Cardioversion when taking Omacor. It is created by eHealthMe based on reports of 2,506 people who have side effects when taking Omacor from the FDA, and is updated regularly.

What is Omacor?

Omacor has active ingredients of omega-3acid ethyl esters. It is often used in high blood cholesterol. eHealthMe is studying from 2,547 Omacor users. Check the latest studies of Omacor.

What is Cardioversion?

Cardioversion is found to be associated with 187 drugs and 345 conditions by eHealthMe. Check the latest studies of Cardioversion.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 22, 2026

2,506 people reported to have side effects when taking Omacor.
Among them, 11 people (0.44%) have Cardioversion.

Among these 11 people:

What is the gender of people who have Cardioversion when taking Omacor? *

female: 0.0 %
male: 100 %

What is the age of people who have Cardioversion when taking Omacor? *

What are other drugs people take besides Omacor? *

Tasigna: 8 people, 72.73%
Torsemide: 5 people, 45.45%
Captopril: 5 people, 45.45%
Acetylsalicylic Acid: 4 people, 36.36%

What are other side effects people have besides Cardioversion? *

Ventricular Fibrillation (abnormally irregular heart rhythm): 11 people, 100.00%
Stable Angina (a constant chest pain): 11 people, 100.00%
Femoral Arterial Stenosis (narrowing of artery of femur bone): 11 people, 100.00%
Coronary Heart Disease (narrowing or blockage of the coronary arteries): 11 people, 100.00%
Coronary Artery Stenosis (narrowing of coronary artery): 11 people, 100.00%
Chest Pain: 11 people, 100.00%
Arteriosclerosis Coronary Artery (thickening and hardening of arteries- coronary artery): 9 people, 81.82%
Peripheral Arterial Occlusive Disease (reproducible ischemic muscle pain): 8 people, 72.73%
Iliac Artery Stenosis (the abnormal narrowing of a iliac artery): 8 people, 72.73%
Gait Disturbance: 8 people, 72.73%

What are the existing conditions these people have? *

High Blood Pressure: 11 people, 100.00%
Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 11 people, 100.00%
Acute Coronary Syndrome (acute chest pain and other symptoms that happen because the heart does not get blood): 11 people, 100.00%
Ventricular Extrasystoles (premature cardiac contraction): 9 people, 81.82%

* Approximation only. Some reports may have incomplete information.

Do you take Omacor and have Cardioversion?

- Check whether Cardioversion is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Omacor:

Omacor (2,547 reports)

Cardioversion treatments and more:

Cardioversion (2,120 reports)

Browse all side effects of Omacor:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Cardioversion:

Cardioversion (187 drugs)

Browse all the conditions that are associated with Cardioversion:

Cardioversion (345 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on omega-3acid ethyl esters (the active ingredients of Omacor) and Omacor (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.